Deletion of the inhibitory co-receptor CTLA-4 enhances and invigorates chimeric antigen receptor T cellsSangya Agarwal, Carl H. June, Weimin Kong et al.|Immunity|2023Cited by 164
Potentiating adoptive cell therapy using synthetic IL-9 receptorsAnusha Kalbasi, K. Christopher García, Mikko Siurala et al.|Nature|2022Cited by 115
Identifying highly active anti-CCR4 CAR T cells for the treatment of T-cell lymphomaKeisuke Watanabe, Carl H. June, Angela M. Gomez et al.|Blood Advances|2023Cited by 43
Abstract 5571: Disruption of cell-intrinsic checkpoint regulator CTLA-4 in CD19 directed CAR T cells provides clinical efficacy in CLL patientsSangya Agarwal, Carl H. June, Angela Aznar Gomez et al.|Cancer Research|2022Cited by 2
Publisher Correction: Potentiating adoptive cell therapy using synthetic IL-9 receptorsAnusha Kalbasi, K. Christopher García, Mikko Siurala et al.|Nature|2022Cited by 2